Jul 10, 2024, 00:53
Tandem autologous stem cell transplantation does not benefit high-risk myeloma patients
Christopher P Venner et al. on X:
at Alfaisal University, shared a paper by “Tandem autologous stem cell transplantation does not benefit high-risk myeloma patients in the maintenance era:
Real-world results from the canadian myeloma research group database.”
Source: Mostafa Faisal/X
Authors: Christopher P Venner, Peter Duggan, Kevin Song, Donna Reece, Smriti Sharma, Jiandong Su, Victor H Jimenez-Zepeda, Arleigh McCurdy, Martha Louzada, Hira Mian, Michael Sebag, Darrell White, Julie Stakiw, Rami Kotb, Muhammad Aslam, Anthony Reiman, Engin Gul, Michael P Chu, Debra Bergstrom and Richard LeBlanc.
Alfaisal University
Anthony Reiman
Arleigh McCurdy
cancer
Christopher P Venner
Darrell White
Debra Bergstrom
Donna Reece
Engin Gul
Hira Mian
Jiandong Su
Julie Stakiw
Kevin Song
Martha Louzada
Michael P Chu
Michael Sebag
Mostafa Faisal
Muhammad Aslam
Myeloma
myeloma patients
myeloma research
OncoDaily
Oncology
Peter Duggan
Rami Kotb
Richard LeBlanc
Smriti Sharma
Stem Cell
Victor H Jimenez-Zepeda
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 1, 2024, 19:12
Nov 1, 2024, 17:46
Nov 1, 2024, 17:41
Nov 1, 2024, 17:27